Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GeoVax Labs
AddedFeb 19, 2024
UpdatedJun 18, 2026
GeoVax Labs

GeoVax Labs

Public

GeoVax Labs Inc.: A biotech firm specializing in the development and commercialization of vaccines for HIV-1 and other diseases.

HQ
Smyrna, GA, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

GeoVax Labs Inc., founded with a mission to serve humanity through innovations in immunology, is a clinical-stage biotechnology company focused on developing vaccines and immunotherapies for infectious diseases and cancer. Utilizing novel proprietary platforms, GeoVax's product portfolio includes Gedeptin®, aimed at treating advanced head and neck cancers, and GEO-CM04S1, a next-generation COVID-19 vaccine currently in Phase II clinical trials. The company targets both the biomedical and pharmaceutical markets with its cutting-edge solutions.

Notable figures affiliated with GeoVax include key researchers and scientists who drive their innovative programs. The company has garnered attention from investors interested in pioneering healthcare solutions. GeoVax's achievements include advancing their oncology and infectious disease programs to critical clinical trial phases, demonstrating significant potential in addressing unmet medical needs. Their impact is marked by contributions to vaccine development and cancer treatment, positioning them as a significant player in the biotech industry.

GeoVax Labs - Similar Companies

Dynavax Technologies logo

Dynavax Technologies

dynavax.com

Novavax logo

Novavax

novavax.com

Agilvax logo

Agilvax

Pathovax logo

Pathovax

pathovax.com

X-Vax Technology logo

X-Vax Technology

Vaccinex logo

Vaccinex

vaccinex.com

EpiVax Oncology logo

EpiVax Oncology

epivaxtx.com

PaxVax logo

PaxVax

Imvax logo

Imvax

imvax.com

Genvax Technologies logo

Genvax Technologies

Epivax logo

Epivax

epivax.com

Codagenix logo

Codagenix

codagenix.com

MimiVax logo

MimiVax

mimivax.com

AmplifyBio logo

AmplifyBio

Centivax logo

Centivax

centivax.com

GeoVax Labs - Quick Facts

Who are GeoVax Labs' competitors?

Companies similar to GeoVax Labs include Dynavax Technologies, Novavax, Agilvax and Pathovax.

When was GeoVax Labs founded?

GeoVax Labs was founded in 2001.

Where is GeoVax Labs' headquarters located?

GeoVax Labs' headquarters is located in Smyrna, GA, US.

When was GeoVax Labs' last funding round?

GeoVax Labs' most recent funding round was for $10M (USD) in January 2022.

How much has GeoVax Labs raised to-date?

As of Jan 14, 2022, GeoVax Labs has raised a total of $28M (USD).

How many employees does GeoVax Labs have?

GeoVax Labs has 14 employees as of Feb 6, 2024.

GeoVax Labs - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Vaccines
Tags
  • Biotech
Unique IDs
  • ein: 870455038
  • secCik: 0000832489
  • ticker: GOVX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 541713Research and Development in Nanotechnology
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 3500Industrial And Commercial Machinery And Computer Equipment
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 3570Computer And Office Equipment
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering